Calypte gets HIV test order in Burkina Faso:
This article was originally published in Clinica
Executive Summary
Alameda, California-based Calypte Biomedical has received its first West African order for its urine-based HIV-1 antibody test, for use in Burkina Faso, which has a population of some 12 million people, with an adult HIV rate of 6.5%. "We would expect that as word of favourable experience with Calypte's urine HIV test spreads, this initial order should drive future sales, not only in Burkina, but elsewhere in the region," said Tony Cataldo, chairman. The company is using a Burkinabe distributor and hopes to expand into Benin, Togo, Ivory Coast, Mali and Niger over the next year.